Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma
- 12 October 2023
- journal article
- research article
- Published by Elsevier in Oral Oncology
- Vol. 147, 106583
Abstract
No abstract availableKeywords
Funding Information
- Sun Yat-sen University (2015020)
- Guangzhou Municipal Science and Technology Program key projects (2023A04J1788)
- Sun Yat-sen University Cancer Center
- Basic and Applied Basic Research Foundation of Guangdong Province (2022A1515110356)
This publication has 37 references indexed in Scilit:
- Locoregional radiotherapy in patients with distant metastases of nasopharyngeal carcinoma at diagnosisChinese Journal of Cancer, 2013
- Prospective Study of Tailoring Whole-Body Dual-Modality [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography With Plasma Epstein-Barr Virus DNA for Detecting Distant Metastasis in Endemic Nasopharyngeal Carcinoma at Initial StagingJournal of Clinical Oncology, 2013
- Comparison of five cisplatin-based regimens frequently used as the first-line protocols in metastatic nasopharyngeal carcinomaJournal of Cancer Research and Clinical Oncology, 2012
- How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapyCancer, 2010
- Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literatureHead & Neck, 2010
- Treatment Outcomes of Patients with AJCC Stage IVC Nasopharyngeal Carcinoma: Benefits of Primary RadiotherapyJapanese Journal of Clinical Oncology, 2006
- X-TileClinical Cancer Research, 2004
- Comparison of plasma Epstein–Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinomaCancer, 2004
- Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: Overall survival and patterns of failureInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992